Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects

NCT02641990 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Premenopausal Female Volunteers

Interventions

DRUG: ITCA 650 20/60 mcg/day, ITCA placebo
DRUG: ITCA placebo, ITCA 650 20/60 mcg/day

Sponsor

Intarcia Therapeutics